ACE2 and COVID-19: COVID-19-specific mechanisms such as increased levels of IFN-γ (292) and reduction of ACE2 levels (293, 294) following SARS-CoV-2 infection could contribute to insulin resistance in skeletal muscle, although specific evidence is lacking.